KLOW

Description

KLOW 80mg — Multi-Peptide Tissue & Mucosal Research Blend

KLOW is a Phase One Labz four-peptide research blend designed for comprehensive investigations into tissue regeneration, mucosal integrity, and dermatological biology from a single reconstituted vial. The blend brings together regenerative, cytoprotective, and anti-inflammatory peptides that target distinct-but-converging pathways in the matrix-remodeling cascade.

Mechanism of Action

Each component in KLOW engages a separate node of the repair network: KPV suppresses NF-κB-driven inflammation at the transcriptional level; GHK-Cu modulates gene expression governing collagen, decorin, and matrix remodeling enzymes; TB-500 mobilizes actin-binding activity to accelerate cell migration and capillary formation; and BPC-157 upregulates growth-factor signaling (VEGF, EGF, FGF) and nitric oxide pathways. The combined profile covers inflammation control, matrix synthesis, cell migration, and angiogenesis simultaneously — a research configuration that no single peptide reproduces.

Research Applications

• Multi-pathway matrix-remodeling cascade studies
• Gut barrier integrity and mucosal repair research
• Dermal and hair-follicle regeneration investigations
• Combined anti-inflammatory and regenerative mechanisms
• Synergistic vs single-compound comparative studies
• Soft tissue and tendon repair research

Product Specifications

• Total Content: 80mg blended per vial
• Composition: KPV, GHK-Cu, TB-500, BPC-157 (co-formulated)
• Purity: ≥99% each component (HPLC verified)
• Form: Lyophilized powder
• Storage: Refrigerate after reconstitution
• Testing: Third-party lab tested, COA available on Portal
• Actual Tested Value: 87.55 mg

For research purposes only. Not for human or veterinary use.